Exploring BK Channelopathies in Fragile X and Other Genetic Syndromes Impacting Neurodevelopment to Illuminate New Frontiers for Functional Biomarkers

Time: 2:15 pm
day: Day Two


  • Laying out the rationale for targeting BK channels in therapeutic development for Fragile X and related genetic syndromes of neurodevelopment
  • Introducing the use of electroretinography (ERG) as a quantitative biomarker for advancing BK channel therapeutics